Pulmonology Medical News about Sleep Apnea, Obstructive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Continuous positive airway pressure device-based automated detection of obstructive sleep apnea compared to standard laboratory polysomnography
Sleep and Breathing, 10/28/09

Prasad B et al. – The monitoring of residual sleep–disordered breathing on treatment, in addition to adherence, is an important objective therapeutic target in OSA. The REMstar Pro detects sleep–disordered breathing events similar to that of a manually scored PSG—for apnea but not for hypopnea—and merits further investigation as a device to determine disease severity and treatment efficacy.

<< Previous
Pneumonia and Influenza Hospitalizations in Elderly People with...

Next >>
Postoperative Pulmonary Complications after Laparotomy

Upper Esophageal Sphincter and Gastroesophageal Junction Pressure Changes Act to Prevent Gastroesophageal and Esophagopharyngeal Reflux during Apneic Episodes in Patients with Obstructive Sleep Apnea
Chest, 11/17/09 Relevance Score: 83%

Sleep and Sleep Disorders in Chronic Obstructive Pulmonary Disease
Respiration, 11/12/09 Relevance Score: 83%

Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome
Sleep and Breathing, 10/21/09 Relevance Score: 83%

Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death
Sleep and Breathing, 10/06/09 Relevance Score: 83%

Screening for Obstructive Sleep Apnea on the Internet: Randomized Trial
American Journal of Medicine, 10/02/09 Relevance Score: 83%